Jungner I - Search Results

1

Levels of lipids and apolipoproteins in three cultures.

Solhpour A, Parkhideh S, Sarrafzadegan N, Asgary S, Williams K, Jungner I, Aastveit A, Walldius G, Sniderman A. Solhpour A, et al. Among authors: jungner i. Atherosclerosis. 2009 Nov;207(1):200-7. doi: 10.1016/j.atherosclerosis.2009.09.003. Epub 2009 Sep 6. Atherosclerosis. 2009. PMID: 19766218

2

Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease.

Sniderman AD, Holme I, Aastveit A, Furberg C, Walldius G, Jungner I. Sniderman AD, et al. Among authors: jungner i. Am J Cardiol. 2007 Jul 15;100(2):217-21. doi: 10.1016/j.amjcard.2007.02.086. Epub 2007 May 30. Am J Cardiol. 2007. PMID: 17631073

3

Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.

Sniderman AD, Jungner I, Holme I, Aastveit A, Walldius G. Sniderman AD, et al. Among authors: jungner i. J Intern Med. 2006 May;259(5):455-61. doi: 10.1111/j.1365-2796.2006.01649.x. J Intern Med. 2006. PMID: 16629851 Free article.

4

[Apolipoproteins are new and better risk indicators of myocardial infarction].

Walldius G, Jungner I. Walldius G, et al. Among authors: jungner i. Lakartidningen. 2004 Mar 25;101(13):1188-94. Lakartidningen. 2004. PMID: 15101244 Review. Swedish.

5

Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke.

Walldius G, Jungner I. Walldius G, et al. Among authors: jungner i. Curr Opin Cardiol. 2007 Jul;22(4):359-67. doi: 10.1097/HCO.0b013e3281bd8849. Curr Opin Cardiol. 2007. PMID: 17556890 Review.

6

Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I--new risk factors and targets for therapy.

Walldius G, Jungner I. Walldius G, et al. Among authors: jungner i. Nutr Metab Cardiovasc Dis. 2007 Oct;17(8):565-71. doi: 10.1016/j.numecd.2007.02.010. Epub 2007 Jul 16. Nutr Metab Cardiovasc Dis. 2007. PMID: 17631989

7

Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Holme I, et al. Among authors: jungner i. Atherosclerosis. 2010 Nov;213(1):299-305. doi: 10.1016/j.atherosclerosis.2010.08.049. Epub 2010 Aug 19. Atherosclerosis. 2010. PMID: 20843515

8

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.

Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frohlich J, Jungner I, Walldius G. Sniderman AD, et al. Among authors: jungner i. Lancet. 2003 Mar 1;361(9359):777-80. doi: 10.1016/s0140-6736(03)12663-3. Lancet. 2003. PMID: 12620753 No abstract available.

9

Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS).

Holme I, Aastveit AH, Jungner I, Walldius G. Holme I, et al. Among authors: jungner i. J Intern Med. 2008 Jul;264(1):30-8. doi: 10.1111/j.1365-2796.2008.01925.x. Epub 2008 Feb 21. J Intern Med. 2008. PMID: 18298486 Free article.

10

The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.

Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD. Walldius G, et al. Among authors: jungner i. Clin Chem Lab Med. 2004;42(12):1355-63. doi: 10.1515/CCLM.2004.254. Clin Chem Lab Med. 2004. PMID: 15576296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters